Biden Adminstration Announces Medicare Drug Negotiation Drugs
Medicare will negotiate the prices of top-selling drugs for blood clots, diabetes, cancer and arthritis, flexing newly granted…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
OPDP Issues Untitled Letter to Exeltis
On August 11, 2023, the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) issued an…
CMS Issues Civil Monetary Penalties for Hospital Price Transparency Rule…
This summer, the United States Centers for Medicare and Medicaid Services (CMS) issued multiple civil monetary penalty (CMP)…
Concerns Over Changes to Third-Party Vendors for REMS Systems
Earlier this year, the United States Food and Drug Administration (FDA) published a Federal Register notice requesting comments on…
Humana Sues HHS Over Medicare Advantage Audit Final Rule
Humana is suing the United States Department of Health and Human Services (HHS) over the plan to audit Medicare Advantage…
House Subcommittee on Health Discusses Many Bills that Could Help Seniors…
The United States House of Representatives Energy and Commerce Committee Subcommittee on Health recently held a hearing,…
Artificial Intelligence in the Health Care Industry – Current Trends
Artificial intelligence – or AI – is a popular buzzword right now. But what does it mean for the health care industry? While it…
FTC Reaches Anti-Trust Settlement with Surescripts
Recently, the United States Federal Trade Commission (FTC) announced a settlement with Surescripts over the company’s alleged use…
2023 PCE Oncology Fall Conferences: An Essential Learning Opportunity for…
In the ever-evolving field of oncology, staying up to date with the latest advancements and best practices is crucial for…
CMS Announces New Slate of Reduced Coinsurance Drugs for Q4 2023
Recently, the Centers for Medicare and Medicaid Services (CMS) announced a third set of Medicare Part B prescription drugs that…